Cargando…
Antithrombin supplementation during extracorporeal membrane oxygenation: study protocol for a pilot randomized clinical trial
BACKGROUND: Normal levels of plasma antithrombin (AT) activity might decrease heparin requirements to achieve an adequate level of anticoagulation during treatment with extracorporeal membrane oxygenation (ECMO). Acquired AT deficiency during ECMO is common, but formal recommendations on target, tim...
Autores principales: | Panigada, Mauro, Spinelli, Elena, Cucino, Alberto, Cipriani, Elisa, De Falco, Stefano, Panarello, Giovanna, Occhipinti, Giovanna, Arcadipane, Antonio, Sales, Gabriele, Fanelli, Vito, Brazzi, Luca, Novembrino, Cristina, Consonni, Dario, Pesenti, Antonio, Grasselli, Giacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558738/ https://www.ncbi.nlm.nih.gov/pubmed/31186035 http://dx.doi.org/10.1186/s13063-019-3386-4 |
Ejemplares similares
-
The relationship between antithrombin administration and inflammation during veno-venous ECMO
por: Panigada, Mauro, et al.
Publicado: (2022) -
Thromboelastography-based anticoagulation management during extracorporeal membrane oxygenation: a safety and feasibility pilot study
por: Panigada, Mauro, et al.
Publicado: (2018) -
Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study
por: Fanelli, Vito, et al.
Publicado: (2022) -
Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
por: Panigada, Mauro, et al.
Publicado: (2020) -
Apneic Tracheostomy in COVID-19 Patients on Veno-Venous Extracorporeal Membrane Oxygenation
por: Rossetti, Matteo, et al.
Publicado: (2021)